Shenzhen Neptunus Interlong Bio-technique Company Limited

HK$0.12As of Sun 8 Nov 2026, 12:00 UTC
HKEX:8329Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (9.17%)
Div yield —
ROE (8.90%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.10)
PE TTM —
TSR TTM (18.62%)
Mkt cap HK$198.0M
ROIC 1.49%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.114
(3.26%)
(27.87%)
Sell 1|8|1|6|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
—
—
—
—
17.07%
16.59%
12.20%
12.34%
Revenue¥M
22.77
24.06
24.93
24.23
8.43%
11.03%
13.98%
9.48%
Peers (US$25.26M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.501
0.434
0.432
EBIT/Intx
2.352
0.117
0.116
Own earn%
61.08
(58.37)
(52.93)
Sh yield%
39.11
36.37
41.00
Owners
Insiders/Inst%
10.70
85.78
Short interest%
2.02
SBC / revenue%
4.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
4–11
$1 testx
—
Incr. ROIC%
4